| 000 | 01366 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513220458.0 | ||
| 264 | 0 | _c20001002 | |
| 008 | 200010s 0 0 eng d | ||
| 022 | _a0007-1048 | ||
| 024 | 7 |
_a10.1046/j.1365-2141.2000.02014.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrentice, H G | |
| 245 | 0 | 0 |
_aTowards a targeted, risk-based, antifungal strategy in neutropenic patients. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cAug 2000 |
||
| 300 |
_a273-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBacteremia _xcomplications |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aGlucocorticoids _xadverse effects |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMycoses _xetiology |
| 650 | 0 | 4 |
_aNeutropenia _xetiology |
| 650 | 0 | 4 |
_aOpportunistic Infections _xprevention & control |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aKibbler, C C | |
| 700 | 1 | _aPrentice, A G | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 110 _gno. 2 _gp. 273-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2141.2000.02014.x _zAvailable from publisher's website |
| 999 |
_c10918823 _d10918823 |
||